• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    5/26/22 12:15:27 PM ET
    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NRIX alert in real time by email

     

    On Thursday, 94 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Medtronic (NYSE:MDT) was the biggest company on a market cap basis to set a new 52-week low.
    • Performance Shipping (NASDAQ:PSHG) was the smallest company when considering market cap to set a new 52-week low.
    • NRX Pharmaceuticals (NASDAQ:NRXP)'s stock came under the most pressure, trading down 63.34% to reach a new 52-week low.
    • Centogene (NASDAQ:CNTG)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    Stocks that set new 52-week lows on Thursday are as follows:

    • Medtronic (NYSE:MDT) stock drifted down 4.4% on Thursday morning to hit a new 52-week low of $98.18.
    • Snowflake (NYSE:SNOW) stock set a new 52-week low of $112.10 on Thursday, moving down 7.55%.
    • Datadog (NASDAQ:DDOG) shares reached a new 52-week low of $82.21 on Thursday morning, moving down 0.1%.
    • MongoDB (NASDAQ:MDB) stock dropped to a yearly low on Thursday of $213.70. Shares traded down 1.77%.
    • Amerco (NASDAQ:UHAL) shares set a new 52-week low of $481.02. The stock traded down 2.55%.
    • Endava (NYSE:DAVA) shares set a new yearly low of $86.17 this morning. The stock was up 3.63% on the session.
    • Nutanix (NASDAQ:NTNX) shares were down 26.52% for the day, having made a 52-week low of $13.51.
    • Super Group (SGHC) (NYSE:SGHC) stock drifted up 0.63% on Thursday morning to hit a new 52-week low of $6.01.
    • Manchester United (NYSE:MANU) stock achieved a new 52-week low on Thursday morning, hitting $10.51 and moving down 10.76%.
    • Jack In The Box (NASDAQ:JACK) shares fell to $65.00 on Thursday, setting a new 52-week low with a shift of down 2.79%.
    • Taro Pharmaceutical Indus (NYSE:TARO) stock set a new 52-week low of $33.59 on Thursday, moving down 6.0%.
    • Zuora (NYSE:ZUO) shares fell to $8.50 on Thursday, setting a new 52-week low with a shift of up 3.88%.
    • Marathon Digital Holdings (NASDAQ:MARA) shares set a new yearly low of $8.53 this morning. The stock was up 2.91% on the session.
    • Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved down 3.17% on Thursday to hit a new 52-week low of $16.02, drifting down 3.17%.
    • Columbus McKinnon (NASDAQ:CMCO) stock broke to a new 52-week low of $30.13 on Thursday. Shares of the company traded down 1.96%.
    • Morphic Holding (NASDAQ:MORF) shares made a new 52-week low of $21.10 on Thursday. The stock was up 4.74% for the day.
    • Riot Blockchain (NASDAQ:RIOT) stock achieved a new 52-week low on Thursday morning, hitting $5.97 and moving up 3.89%.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPB) shares fell to $9.55 on Thursday, setting a new 52-week low with a shift of up 5.05%.
    • TrueBlue (NYSE:TBI) shares hit a yearly low of $19.20. The stock was down 6.96% on the session.
    • RedBall Acquisition (NYSE:RBAC) shares set a new 52-week low of $8.86. The stock traded down 5.16%.
    • Merus (NASDAQ:MRUS) shares moved down 3.38% on Thursday to hit a new 52-week low of $13.92, drifting down 3.38%.
    • Haymaker Acquisition (NASDAQ:HYAC) shares hit a yearly low of $9.41. The stock was down 4.23% on the session.
    • Stoke Therapeutics (NASDAQ:STOK) shares made a new 52-week low of $11.64 on Thursday. The stock was down 1.16% for the day.
    • Hut 8 Mining (NASDAQ:HUT) stock hit a new 52-week low of $2.10. The stock was up 2.9% on the session.
    • Albireo Pharma (NASDAQ:ALBO) stock achieved a new 52-week low on Thursday morning, hitting $19.87 and moving up 0.94%.
    • Nurix Therapeutics (NASDAQ:NRIX) stock achieved a new 52-week low on Thursday morning, hitting $7.52 and moving down 21.98%.
    • Monte Rosa Therapeutics (NASDAQ:GLUE) shares made a new 52-week low of $7.19 on Thursday. The stock was up 1.94% for the day.
    • Bitfarms (NASDAQ:BITF) stock broke to a new 52-week low of $1.61 on Thursday. Shares of the company traded up 2.98%.
    • Heron Therapeutics (NASDAQ:HRTX) shares made a new 52-week low of $3.05 on Thursday. The stock was up 4.68% for the day.
    • Latch (NASDAQ:LTCH) stock achieved a new 52-week low on Thursday morning, hitting $2.01 and moving up 7.28%.
    • NextNav (NASDAQ:NN) stock dropped to a yearly low on Thursday of $3.08. Shares traded down 3.06%.
    • OraSure Technologies (NASDAQ:OSUR) stock hit a yearly low of $4.00. The stock was down 2.77% for the day.
    • Avaya Hldgs (NYSE:AVYA) shares hit a yearly low of $2.93. The stock was up 4.81% on the session.
    • Veritone (NASDAQ:VERI) stock drifted up 3.67% on Thursday morning to hit a new 52-week low of $7.14.
    • Aerie Pharmaceuticals (NASDAQ:AERI) stock hit a new 52-week low of $5.33. The stock was up 0.91% on the session.
    • Biotech Acquisition (NASDAQ:BIOT) shares moved down 9.73% on Thursday to hit a new 52-week low of $8.30, drifting down 9.73%.
    • Ocular Therapeutix (NASDAQ:OCUL) stock dropped to a yearly low on Thursday of $2.95. Shares traded down 1.47%.
    • Macrogenics (NASDAQ:MGNX) stock drifted down 0.28% on Thursday morning to hit a new 52-week low of $3.48.
    • Cryptyde (NASDAQ:TYDEV) shares set a new 52-week low of $10.70. The stock traded down 20.74%.
    • Jounce Therapeutics (NASDAQ:JNCE) shares set a new 52-week low of $3.73. The stock traded up 0.26%.
    • Alpha Teknova (NASDAQ:TKNO) shares moved up 2.33% on Thursday to hit a new 52-week low of $6.38, drifting up 2.33%.
    • Accuray (NASDAQ:ARAY) stock drifted up 0.99% on Thursday morning to hit a new 52-week low of $2.00.
    • Fusion Pharmaceuticals (NASDAQ:FUSN) stock drifted down 0.93% on Thursday morning to hit a new 52-week low of $3.70.
    • Yiren Digital (NYSE:YRD) shares made a new 52-week low of $1.56 on Thursday. The stock was down 7.23% for the day.
    • Zepp Health (NYSE:ZEPP) shares made a new 52-week low of $1.99 on Thursday. The stock was up 3.47% for the day.
    • Ovid Therapeutics (NASDAQ:OVID) stock set a new 52-week low of $1.78 on Thursday, moving down 3.26%.
    • OFS Credit (NASDAQ:OCCI) shares were up 1.08% for the day, having made a 52-week low of $10.01.
    • Shattuck Labs (NASDAQ:STTK) stock hit a yearly low of $2.59. The stock was up 0.18% for the day.
    • CytomX Therapeutics (NASDAQ:CTMX) stock drifted up 0.98% on Thursday morning to hit a new 52-week low of $1.50.
    • Exela Technologies (NASDAQ:XELA) shares were up 0.05% for the day, having made a 52-week low of $0.21.
    • Avadel Pharmaceuticals (NASDAQ:AVDL) shares hit a yearly low of $1.57. The stock was down 52.96% on the session.
    • AstroNova (NASDAQ:ALOT) stock achieved a new 52-week low on Thursday morning, hitting $11.79 and moving down 1.96%.
    • TCR2 Therapeutics (NASDAQ:TCRR) shares set a new 52-week low of $2.06. The stock traded up 1.42%.
    • Akumin (NASDAQ:AKU) stock set a new 52-week low of $0.84 on Thursday, moving down 2.26%.
    • Quanergy Systems (NYSE:QNGY) stock drifted up 0.49% on Thursday morning to hit a new 52-week low of $0.78.
    • Comera Life Sciences (NASDAQ:CMRA) stock set a new 52-week low of $4.22 on Thursday, moving down 15.33%.
    • Centogene (NASDAQ:CNTG) stock dropped to a yearly low on Thursday of $2.59. Shares traded 0.0% (flat).
    • Visionary Education Tech (NASDAQ:VEDU) stock hit a new 52-week low of $1.35. The stock was up 7.24% on the session.
    • Rain Therapeutics (NASDAQ:RAIN) shares set a new 52-week low of $2.17. The stock traded up 1.81%.
    • Verrica Pharmaceuticals (NASDAQ:VRCA) stock broke to a new 52-week low of $1.80 on Thursday. Shares of the company traded up 0.05%.
    • Molecular Templates (NASDAQ:MTEM) stock dropped to a yearly low on Thursday of $0.94. Shares traded down 5.83%.
    • Ocean Power Technologies (AMEX:OPTT) shares moved down 4.23% on Thursday to hit a new 52-week low of $0.89, drifting down 4.23%.
    • Charles & Colvard (NASDAQ:CTHR) stock achieved a new 52-week low on Thursday morning, hitting $1.32 and moving up 0.75%.
    • Societal CDMO (NASDAQ:SCTL) shares reached a new 52-week low of $0.71 on Thursday morning, moving down 1.2%.
    • Spero Therapeutics (NASDAQ:SPRO) shares moved down 0.42% on Thursday to hit a new 52-week low of $1.17, drifting down 0.42%.
    • PhaseBio Pharmaceuticals (NASDAQ:PHAS) stock broke to a new 52-week low of $0.74 on Thursday. Shares of the company traded up 3.54%.
    • Tenon Medical (NASDAQ:TNON) stock hit a yearly low of $3.05. The stock was up 1.59% for the day.
    • Kala Pharmaceuticals (NASDAQ:KALA) stock achieved a new 52-week low on Thursday morning, hitting $0.37 and moving down 5.0%.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) stock achieved a new 52-week low on Thursday morning, hitting $1.64 and moving down 1.15%.
    • Firsthand Tech Value Fund (NASDAQ:SVVC) shares set a new 52-week low of $2.70. The stock traded down 1.84%.
    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) shares made a new 52-week low of $0.33 on Thursday. The stock was up 3.83% for the day.
    • Pasithea Therapeutics (NASDAQ:KTTA) stock drifted down 0.4% on Thursday morning to hit a new 52-week low of $0.81.
    • Locafy (NASDAQ:LCFY) shares hit a yearly low of $0.80. The stock was up 4.27% on the session.
    • Shineco (NASDAQ:SISI) shares set a new 52-week low of $1.61. The stock traded down 1.2%.
    • Advanced Human Imaging (NASDAQ:AHI) shares fell to $0.67 on Thursday, setting a new 52-week low with a shift of down 5.84%.
    • Secoo Holding (NASDAQ:SECO) shares set a new yearly low of $0.22 this morning. The stock was down 4.76% on the session.
    • BIO-key Intl (NASDAQ:BKYI) stock set a new 52-week low of $1.76 on Thursday, moving down 3.03%.
    • Windtree Therapeutics (NASDAQ:WINT) stock broke to a new 52-week low of $0.45 on Thursday. Shares of the company traded up 3.06%.
    • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares were down 0.83% for the day, having made a 52-week low of $1.14.
    • INVO Bioscience (NASDAQ:INVO) stock set a new 52-week low of $0.85 on Thursday, moving down 3.17%.
    • JX Luxventure (NASDAQ:LLL) shares reached a new 52-week low of $1.28 on Thursday morning, moving down 3.57%.
    • Blue Hat Interactive (NASDAQ:BHAT) stock hit $0.15 on Thursday morning, setting a new 52-week low for a change of down 14.72%.
    • Viveve Medical (NASDAQ:VIVE) stock drifted up 3.86% on Thursday morning to hit a new 52-week low of $0.72.
    • AutoWeb (NASDAQ:AUTO) shares hit a yearly low of $0.49. The stock was up 1.57% on the session.
    • Acorda Therapeutics (NASDAQ:ACOR) stock broke to a new 52-week low of $0.40 on Thursday. Shares of the company traded up 1.22%.
    • Performance Shipping (NASDAQ:PSHG) stock drifted down 4.16% on Thursday morning to hit a new 52-week low of $1.80.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $NRIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NRIX
    $NRXP
    $NTNX
    $OCCI

    CompanyDatePrice TargetRatingAnalyst
    Datadog Inc.
    $DDOG
    4/23/2026$170.00Buy
    Rothschild & Co Redburn
    NextNav Inc.
    $NN
    4/16/2026$25.00Perform → Outperform
    Oppenheimer
    Nutanix Inc.
    $NTNX
    4/10/2026$44.00Overweight → Neutral
    Analyst
    MacroGenics Inc.
    $MGNX
    4/10/2026$9.00Neutral → Buy
    B. Riley Securities
    Datadog Inc.
    $DDOG
    4/9/2026$175.00Neutral → Buy
    Guggenheim
    Nutanix Inc.
    $NTNX
    4/3/2026$60.00Buy
    Rosenblatt
    Nutanix Inc.
    $NTNX
    4/2/2026$60.00Buy
    Rosenblatt
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    More analyst ratings

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcgrath Kenneth J bought $66,030 worth of shares (22,021 units at $3.00), increasing direct ownership by 4% to 557,262 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:53 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    President & CEO Eglinton Manner Carrie bought $66,033 worth of shares (22,022 units at $3.00), increasing direct ownership by 1% to 2,158,574 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:38 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Lowell Matthew bought $87,616 worth of shares (40,000 units at $2.19), increasing direct ownership by 31% to 168,376 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:30:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Le-Quoc Alexis converted options into 43,224 shares and sold $5,655,316 worth of shares (43,224 units at $130.84) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Datadog, Inc. (0001561550) (Issuer)

    4/23/26 5:16:34 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    New insider Huang Jingsheng claimed ownership of 52,076 units of Ordinary Shares (SEC Form 3)

    3 - Yiren Digital Ltd. (0001631761) (Issuer)

    4/23/26 4:25:26 PM ET
    $YRD
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Agarwal Amit

    4 - Datadog, Inc. (0001561550) (Issuer)

    4/22/26 4:04:00 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Datadog with a new price target

    Rothschild & Co Redburn initiated coverage of Datadog with a rating of Buy and set a new price target of $170.00

    4/23/26 7:55:35 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    NextNav upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded NextNav from Perform to Outperform and set a new price target of $25.00

    4/16/26 7:59:04 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Nutanix downgraded by Analyst with a new price target

    Analyst downgraded Nutanix from Overweight to Neutral and set a new price target of $44.00

    4/10/26 8:30:04 AM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    SEC Filings

    View All

    BIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    4/22/26 5:00:39 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by MacroGenics Inc.

    DEFA14A - MACROGENICS INC (0001125345) (Filer)

    4/22/26 4:45:03 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Stoke Therapeutics Inc.

    DEFA14A - Stoke Therapeutics, Inc. (0001623526) (Filer)

    4/22/26 4:09:16 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

    Pre-randomization Atrioventricular Interval Modulation Therapy ("AVIM Therapy") set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an immediate average reduction of 13.2 mmHg in office systolic blood pressure ("oSBP")97% of patients experienced an immediate blood pressure reduction of >5 mmHg reduction in oSBP prior to randomizationAVIM Therapy demonstrated the potential to deliver immediate, substantial, and sustained reductions in blood pressure, with evidence of improved diastolic function and reverse cardiac remodelingThe BACKBEAT Global Pivotal Trial, which Orchestra BioMed is actively enrolling as part of a strategic collaboratio

    4/23/26 12:00:00 PM ET
    $MDT
    $OBIO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medicinal Chemicals and Botanical Products

    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, April 28, 2026 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in Australia, China, Hong Kong, Portugal, Netherlands, Cayman Islands and France, will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live presentations and/or ask qu

    4/23/26 8:35:00 AM ET
    $BLTE
    $HCM
    $LOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    Jack in the Box Announces Second Quarter 2026 Earnings Webcast

    Jack in the Box Inc. (NASDAQ:JACK) announces the following event: What: JACK Q2 2026 Earnings Webcast When: Wednesday, May 13, 2026 at 5 p.m. EDT Where: investors.jackinthebox.com How: Live webcast (web address above) Contact: Rachel Webb, Vice President of Finance and Investor Relations   (858) 522-4556     *This webcast event will be archived on the Jack in the Box investor relations website for replay. *Q2 2026 Earnings Release will go out after market close on Wednesday, May 13. About Jack in the Box Inc. Jack in the Box Inc. (NASDAQ:JACK), founded and headquarte

    4/23/26 7:30:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Leadership Updates

    Live Leadership Updates

    View All

    OraSure Technologies Appoints John D. Bertrand to its Board of Directors

    Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure" and "OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the appointment of John D. Bertrand to its Board of Directors as an independent director, effective immediately. Mr. Bertrand is a healthcare technology executive with more than a decade of experience driving AI-enabled innovation in diagnostics. He co-founded Digital Diagnostics Inc. and most recently served as its Chief Executive Officer,

    4/16/26 8:10:00 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

    Ms. Deardorf is an experienced biopharma leader who will lead business development and corporate and commercial strategy as Neutrolis advances NTR-1011 into autoimmune diseases following positive Phase 1a results CAMBRIDGE, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Neutrolis Inc. a clinical-stage biotechnology company focused on targeting Neutrophil Extracellular Traps (NETs) for the treatment of autoimmune and inflammatory diseases, today announced the appointment of Caren Deardorf as Chief Business & Strategy Officer (CBSO). Ms. Deardorf will lead corporate and pipeline strategy, business development, and early commercial strategy as the company advances its clinical pipeline. Ms. Dear

    4/15/26 2:00:00 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jack in the Box Inc. Advances Board Refreshment with Appointment of Eduardo Luz

    Accomplished Restaurant Executive Joins as Independent Director to Support Transformation David Goebel and Madeleine Kleiner to Retire from the Board Jack in the Box Inc. ("Jack in the Box" or the "Company") (NASDAQ:JACK) today announced that Eduardo Luz has been appointed to its Board of Directors (the "Board") as an independent director. The Company also announced that David Goebel and Madeleine Kleiner will retire from the Board, effective May 8, 2026. With these actions, the Board will reduce its size to nine members. Mr. Luz joins as part of Jack in the Box's continued focus on maintaining a best-in-class Board, which has resulted in significant refreshment over the past year. Th

    4/13/26 4:10:00 PM ET
    $JACK
    Restaurants
    Consumer Discretionary

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Financials

    Live finance-specific insights

    View All

    Jack in the Box Announces Second Quarter 2026 Earnings Webcast

    Jack in the Box Inc. (NASDAQ:JACK) announces the following event: What: JACK Q2 2026 Earnings Webcast When: Wednesday, May 13, 2026 at 5 p.m. EDT Where: investors.jackinthebox.com How: Live webcast (web address above) Contact: Rachel Webb, Vice President of Finance and Investor Relations   (858) 522-4556     *This webcast event will be archived on the Jack in the Box investor relations website for replay. *Q2 2026 Earnings Release will go out after market close on Wednesday, May 13. About Jack in the Box Inc. Jack in the Box Inc. (NASDAQ:JACK), founded and headquarte

    4/23/26 7:30:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary

    OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

    BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business developments for 5 p.m. ET on May 6, 2026. A webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure's website shortly after the call has ended. About OraSure Technologies, Inc. OraSure Technologies, Inc. ("OraSure" and "

    4/22/26 4:10:00 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

    MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026. The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), c

    4/22/26 4:05:00 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Verrica Pharmaceuticals Inc.

    SC 13G/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    12/9/24 6:22:49 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Shattuck Labs Inc.

    SC 13D/A - Shattuck Labs, Inc. (0001680367) (Subject)

    12/6/24 9:03:38 PM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care